Drug Type Small molecule drug |
Synonyms |
Target |
Action antagonists, agonists |
Mechanism 5-HT3 receptor antagonists(5-hydroxytryptamine receptors, ionotropic (HTR3) antagonists), 5-HT4 receptor agonists(Serotonin 4 (5-HT4) receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H27Cl2N3O2 |
InChIKeyGMHMNKHDLXRRGF-UMEYXWOPSA-N |
CAS Registry151213-88-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dyspepsia | Phase 2 | Japan | - | - |
Dyspepsia | Phase 2 | - | - | |
Irritable Bowel Syndrome | Phase 2 | - | - | |
Irritable Bowel Syndrome | Phase 2 | Japan | - | - |